Estrella Immunopharma Inc...
(ESLA) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.19
0.00%
After-hours Jan 07, 2025, 03:59 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -5.3 | -59.53 | -34.71 | -467.79 |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 9.06 | 8.39 | -56.26 | n/a |
P/FCF Ratio | -2.41 | -56.81 | -40.57 | -511.63 |
P/OCF Ratio | -2.41 | -56.81 | -40.57 | -511.63 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0.07 | n/a | n/a |
Quick Ratio | 24.65 | 0.05 | 5.20 | n/a |
Current Ratio | 24.65 | 0.05 | 5.20 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -1.71 | -0.14 | 1.62 | n/a |
Return on Assets (ROA) | -1.64 | -0.1 | -0.34 | n/a |
Return on Capital (ROIC) | -1.71 | -0.18 | -0.42 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |